PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.

by Holger Hans Hermann Erb, Marlies Ebert, Ronja Kuhn, Lukas Donix, Axel Haferkamp, Robert Ian Seed, Eva Jüngel
Published 2019-01-01

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.

by Holger H H Erb, Julia Bodenbender, Florian Handle, Tamara Diehl, Lukas Donix, Igor Tsaur, Martin Gleave, Axel Haferkamp, Johannes Huber, Susanne Fuessel, Eva Juengel, Zoran Culig, Christian Thomas
Published 2020-01-01